Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside-Reference-Cited by-同舟云学术

Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside

Published:2016-05-09 Issue:27 Volume:7 Page:41172-41185
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Fleurence Julien¹²,Cochonneau Denis³,Fougeray Sophie¹²⁴,Oliver Lisa¹²⁵,Geraldo Fanny¹²,Terme Mickaël³,Dorvillius Mylène³,Loussouarn Delphine¹²⁵,Vallette François¹²⁶,Paris François¹²⁵⁶,Birklé Stéphane¹²⁴

Affiliation:

1. INSERM U892, Centre de Recherche en Cancérologie de Nantes-Angers, Institut de Recherche en Santé de l'Université de Nantes, Nantes, France

2. CNRS 6299, Centre de Recherche en Cancérologie de Nantes-Angers, Institut de Recherche en Santé de l'Université de Nantes, Nantes, France

3. OGD2 Pharma, Institut de Recherche en Santé de l'Université de Nantes, Nantes, France

4. Université de Nantes, UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France

5. Centre Hospitalier Universitaire de Nantes, Nantes, France

6. LaBCT, Institut de Cancérologie de l'Ouest-René Gauducheau, Saint-Herblain, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers;International Journal of Molecular Sciences;2024-01-22

2. Development of NHAcGD2/NHAcGD3 conjugates of bacteriophage MX1 virus-like particles as anticancer vaccines;RSC Advances;2024

3. Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings;Brain Sciences;2023-11-17

4. Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements;Frontiers in Bioengineering and Biotechnology;2023-10-06

5. CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies;Frontiers in Immunology;2023-10-03